Drug Type Small molecule drug |
Synonyms Choline salicylate (JAN/USAN/INN), Arthropan |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H19NO4 |
InChIKeyUDKCHVLMFQVBAA-UHFFFAOYSA-M |
CAS Registry2016-36-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Histiocytic and Dendritic Cell Neoplasm | Phase 1 | United States | 08 Feb 2021 | |
| Non-Hodgkin's lymphoma refractory | Phase 1 | United States | 08 Feb 2021 | |
| Recurrent Histiocytic and Dendritic Cell Neoplasm | Phase 1 | United States | 08 Feb 2021 | |
| Recurrent Hodgkin Lymphoma | Phase 1 | United States | 08 Feb 2021 | |
| Recurrent Multiple Myeloma | Phase 1 | United States | 08 Feb 2021 | |
| Recurrent Non-Hodgkin Lymphoma | Phase 1 | United States | 08 Feb 2021 | |
| Refractory Histiocytic and Dendritic Cell Neoplasm | Phase 1 | United States | 08 Feb 2021 | |
| Refractory Hodgkin Lymphoma | Phase 1 | United States | 08 Feb 2021 | |
| Refractory Multiple Myeloma | Phase 1 | United States | 08 Feb 2021 | |
| Relapse multiple myeloma | Phase 1 | United States | 08 Feb 2021 |





